-
Selvendiran Karuppaiyah, PhD,
Ohio State University
Early Career Investigator Grant
New Type of Experimental Drug for Ovarian Cancer
-
Tyler Curiel, MD,
University of Texas Health Science Center at San Antonio
Collaborative Research Development Grant
Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
-
Barbara Stulken Norquist, MD,
University of Washington
Early Career Investigator Grant
Molecular Biomarkers to Predict PARP Inhibitor Response in Ovarian Cancer
-
Matthias Stephan, MD, PhD,
Fred Hutchinson Cancer Research Center
Early Career Investigator Grant
In vivo Programming of Ovarian Tumor-reactive T-cells Using Nanoparticles
-
Ronen Marmorstein, PhD,
University of Pennsylvania
Collaborative Research Development Grant
Chromatin Regulatory Mechanisms in Ovarian Cancer
-
S John Weroha, MD, PhD,
Mayo Clinic
Early Career Investigator Grant
Ovarian Cancer Surrogates to Study Platinum Resistance
-
Ursula Matulonis, MD,
Dana Farber Cancer Institute
Collaborative Research Development Grant
Rational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy
-
Nima Aghaeepour, PhD,
Stanford University
Mentored Investigator Grant
Computationally-guided Characterization of Therapy-resistant Ovarian Tumors
-
Raphael Ceccaldi, PharmD, PhD,
Dana Farber Cancer Institute
Mentored Investigator Grant
A Bioinformatic Screen Identifies POLQ Overexpression in Ovarian Cancers
-
Ilana Chefetz, PhD,
University of Michigan
Mentored Investigator Grant
A Role for ALDH in the Regulation of Necroptosis in Ovarian Cancer Area of research: Therapeutic Targeting
-
Ellen Cheon, PhD,
Cedars-Sinai Medical Center
Mentored Investigator Grant
Collagen-Remodeling Genes Provide a Niche for Ovarian Cancer
-
Laura Dillon, PhD,
University of Virginia
Mentored Investigator Grant
Differential MicroDNA Generation in Ovarian Cancer